8-K 20210528

 







UNITED STATES



SECURITIES AND EXCHANGE COMMISSION



Washington, D.C. 20549



__________



Form 8-K



CURRENT REPORT



Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934



Date of Report (Date of earliest event reported) May  28, 2021



AquaBounty Technologies, Inc.

(Exact name of registrant as specified in its charter)





 

 

Delaware

001-36426

04-3156167

(State or other jurisdiction
of incorporation)

(Commission
File Number)

(IRS Employer
Identification No.)



2 Mill & Main Place,  Suite 395,  Maynard,  Massachusetts

(Address of principal executive offices)

01754

(Zip Code)



978-648-6000

(Registrant’s telephone number, including area code)

(Former name or former address, if changed since last report.)



Title of each class

Trading Symbol(s)

Name of exchange on which registered

Common Stock, par value $0.001 per share

AQB

The NASDAQ Stock Market LLC 



Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:





 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))



Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.



Emerging growth company    



If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.    

 


 

 

Item 5.07 Submission of Matters to a Vote of Security Holders.



On May 28, 2021, the Company held its annual meeting of stockholders. At this meeting, the Company’s stockholders (i) elected each of the persons listed below as a director for a one-year term; and (ii) ratified the appointment of Wolf & Company, P.C. as the Company’s independent registered accounting firm for the fiscal year ending December 31, 2021.



Proposal 1 Election of Directors



 

 

 

 

 

 



 

 

 

 

 

 



 

For

 

Withheld

 

Broker Non-Votes

Richard J. Clothier

 

34,545,685

 

115,912

 

14,192,726

Ricardo J. Alvarez

 

34,545,528

 

116,069

 

14,192,726

Theodore J. Fisher

 

34,545,903

 

115,694

 

14,192,726

Alana D. Kirk

 

34,494,061

 

167,536

 

14,192,726

Gail Sharps Meyers

 

34,539,921

 

121,676

 

14,192,726

Christine St.Clare

 

34,520,761

 

140,836

 

14,192,726

Rick Sterling

 

34,516,163

 

145,434

 

14,192,726

James C. Turk, Jr.

 

34,545,392

 

116,205

 

14,192,726

Sylvia Wulf

 

34,516,528

 

145,069

 

14,192,726



Proposal 2 Ratification of Independent Registered Public Accounting Firm





 

 

 

 

 

 



 

 

 

 

 

 

For

 

Against

 

Abstain

 

Broker Non-Votes

48,528,264

 

156,894

 

169,165

 

 -



Item 7.01 Regulation FD Disclosure.

On May 28, 2021, Sylvia Wulf, the Company’s Chief Executive Officer, announced that the Company had received approval for its application to Brazil’s National Biosafety Technical Commission (CTNBio) for the sale of the Company’s genetically engineered (GE) Atlantic salmon. CTNBio assessed AquaBounty’s application to ensure it met the relevant standards and regulatory requirements and concluded that consuming AquaBounty’s GE salmon is safe for the environment and human health.

The information included in this Current Report on Form 8-K pursuant to Item 7.01 is intended to be furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Securities Exchange Act of 1934, except as expressly set forth by specific reference in such filing.



SIGNATURES



Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.





 

 



 

AquaBounty Technologies, Inc.



 

(Registrant)



 

 

May  28, 2021

 

/s/ David A. Frank



 

David A. Frank



 

Chief Financial Officer